FDA Warning Letter — Jazz Pharmaceuticals, Inc
The FDA took a Warning Letter action against Jazz Pharmaceuticals, Inc on September 18, 2012 (Palo Alto, CA). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Jazz Pharmaceuticals, Inc
- Date
- September 18, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Center
- CDER
- Location
- Palo Alto, CA (United States)